Ronald Dumigan, MD
Orthopaedic Surgery · Oklahoma City, OKNPI 1871685081
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $165,853 of the $169,137 with a category attached, or 98.1%. Anika Therapeutics, Inc. accounts for 62.5% of it on its own, with 10 other manufacturers making up the rest. Among orthopaedic surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $3316.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$106K
- Arthrosurface Incorporated$60K
- Pylant Medical$1K
- Restor3d, Inc.$1K
- Ortho Development Corporation$240
- Arthrex$153
- plus $195 from 5 others
What the payments were for
- Royalty or licence$165,85398%
- Travel & lodging$8951%
- Food & beverage$1,1361%
- Education$1,2541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 18 | $105,683 |
| Arthrosurface Incorporated | 12 | $60,474 |
| Pylant Medical | 3 | $1,326 |
| Restor3d, Inc. | 5 | $1,067 |
| Ortho Development Corporation | 1 | $240 |
| Arthrex | 1 | $153 |
| Pacira Therapeutics, Inc. | 7 | $117 |
| Innovation Technologies Inc | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Merck | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OVOMotion$75,785
- HemiCAP Shoulder$63,968
- OVO Motion$26,100
- BKS TriMax$240
- ENTRADA$240
- Integrity$168
- RevoMotion$135
How this compares
$169,137 in reported general payments places this provider in the 95th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 132 | $1,748 |
| Meloxicam | 161 | $1,156 |
| Celecoxib | 26 | $576 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $330 |
| Ondansetron OdtOndansetron | 35 | $181 |
| Methylprednisolone | 17 | $156 |
| Cephalexin | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oklahoma City
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Paul MaitinoOklahoma City$110K
- Thomas TkachOklahoma City$83K
- Brian LevingsOklahoma City$80K
- Christopher WhiteOklahoma City$73K
- Raymond SteinmetzOklahoma City$64K
- Michael JohnsonOklahoma City$63K
- Ryan NelsonOklahoma City$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.